IOL Chemicals & Pharmaceuticals said that company's product, Ibuprofen has received an approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China.

Peethaambaran Kunnathoor, Chennai Tuesday, April 29, 2025, 08:00 Hrs [IST] ...

Photo shows Dr. Ron Cohen, founder, former chairman and CEO of Acorda Therapeutics, speaking at the healthcare symposium ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 7.27%, which has investors questioning if this is right time ...

If the goal of these cuts was to make the government leaner, the result has been to make it weaker. And in the realm of public health, weakness can be deadly.

Europe should not spearhead the introduction of new trade barriers, warn Danish and Swedish members of the European ...

Sigachi Industries shares jumped 5% from their intraday low on Monday’s stock market session after the company announced an ...

Faster generic approvals make sense, but tariffs will counter the gains.

A proposed 25% tariff on U.S. pharmacy imports would drive up U.S. drug costs by $51 billion annually, according to an analysis by Ernst & Young reviewed by Reuters. The April 22 analysis, ...